The global MRI guided neurosurgical ablation market is set for continued expansion, according to a recent report by Future Market Insights (FMI). Demonstrating significant growth in 2021 with revenues reaching USD 154 million, the market is projected to achieve USD 216.3 million by 2028. This growth reflects a steady compound annual growth rate (CAGR) of 5% from 2022 to 2028.
MRI guided neurosurgical ablation devices are increasingly prominent in the healthcare industry, commanding a substantial 13% share of the global ablation devices market. The demand for MRI-guided neurosurgical ablation accessories is also on the rise, with an anticipated CAGR of 5.8% throughout the forecast period.
“The expansion of the MRI guided neurosurgical ablation market is driven by technological advancements and a growing preference for minimally invasive procedures,” said a Future Market Insights. “These devices are becoming essential in treating neurological disorders, contributing to their widespread adoption.”
MRI guided neurosurgical ablation procedures are favored for their precision in targeting and minimal damage to surrounding tissues, which enhances their appeal to both healthcare providers and patients. As technological innovations continue to evolve, further growth across global regions is expected.
Key Market Insights:
- Market Size & Growth: The global MRI-guided neurosurgical ablation market is forecasted to reach USD 216.3 million by 2028, growing steadily.
- Regional Leadership: The U.S. remains a leader in the market, driven by advanced technologies, robust healthcare infrastructure, and an increasing number of specialized neurosurgeons. Investments by major players and improved outpatient facilities are further advancing the U.S. market.
- Emerging Markets: China presents significant potential with its large patient base, rising healthcare expenditure, and growing medical tourism. The aging population and increased healthcare access are expected to boost market growth in China.
Dive Deep into the Market Trends: Access the Full MRI Guided Neurosurgical Ablation Market Report
Competitive Landscape:
Leading companies in the MRI guided neurosurgical ablation market are focusing on direct collaborations with hospitals and expanding their global presence as part of their long-term growth strategies. For instance, in March 2020, INSIGHTEC invested USD 150 million in developing an incisionless surgical device aimed at treating tremors in Parkinson’s disease patients resistant to medication.
Key Companies in the Market Include:
- Medtronic
- INSIGHTEC
- Boston Scientific Corporation
- Monteris Medical, Inc.
- MRI Interventions, Inc.
- AngioDynamics Inc.
- ClearPoint Neuro, Inc.
- Smith & Nephew plc
- St. Jude Medical, Inc.
Market Segmentation:
By Product Type:
- MRI Guided Laser Therapy Systems
- MRI Guided RF Ablation Systems
- MRI Guided Focused Ultrasound Systems
- Accessories (Probes, Electrodes)
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Research Laboratories
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Pacific
- Middle East & Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube